Enzon Pharmaceuticals, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Enzon Pharmaceuticals, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Enzon Pharmaceuticals, Inc.. The Group's principal activity is to develop, manufacture and sell human therapeutics for life-threatening diseases. The Group includes three segments: Product sale which manufactures markets and sells pharmaceutical products for patients with cancer and other life-threatening diseases. Royalties, a source of revenue which is derived from sales of marketed products from PEG-INTRON, PEGASYS and MACUGEN that utilize our proprietary technology. Contract Manufacturing, where we utilize a portion of our excess manufacturing capacity to provide contract manufacturing services for a number of injectable products, such as single- and dual-chamber vial filling and lipid Complex formulations. The Group's products include ABELCET, ADAGEN, DEPOCYT and ONCASPAR.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report